KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Revenue (2016 - 2025)

Historic Revenue for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $7.8 billion.

  • Gilead Sciences' Revenue rose 296.89% to $7.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 billion, marking a year-over-year increase of 278.46%. This contributed to the annual value of $28.8 billion for FY2024, which is 604.07% up from last year.
  • As of Q3 2025, Gilead Sciences' Revenue stood at $7.8 billion, which was up 296.89% from $7.1 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Revenue registered a high of $7.8 billion during Q3 2025, and its lowest value of $6.2 billion during Q2 2021.
  • In the last 5 years, Gilead Sciences' Revenue had a median value of $7.0 billion in 2022 and averaged $6.9 billion.
  • Per our database at Business Quant, Gilead Sciences' Revenue surged by 2088.28% in 2021 and then tumbled by 510.71% in 2022.
  • Quarter analysis of 5 years shows Gilead Sciences' Revenue stood at $7.2 billion in 2021, then grew by 2.0% to $7.4 billion in 2022, then fell by 3.72% to $7.1 billion in 2023, then increased by 6.4% to $7.6 billion in 2024, then rose by 2.64% to $7.8 billion in 2025.
  • Its last three reported values are $7.8 billion in Q3 2025, $7.1 billion for Q2 2025, and $6.7 billion during Q1 2025.